Objective: To determine zinc status and age-related changes in the immune function of healthy late-middle-aged men and women (aged 55-70 y). Design: Observational study. 
Introduction
Ageing of the immune system (immunosenescence) is a multifaceted process commonly defined as a decline in cellmediated immunity (CMI), which in turn contributes to increased susceptibility to infection, morbidity, and mortality. Alterations of the immune system found in successfully aged individuals, that is healthy centenarians (Paolisso et al, 2000) , have been described as 'primary' age-related changes; 'secondary' alterations of the immune system with age may be a consequence of underlying disease or influence of environmental factors, such as lifestyle (Wick & GrubeckLoebenstein, 1997) . The most striking age-related changes in immunity have been observed in the cell-mediated arm of the immune system (Burns & Goodwin, 2004) . However, virtually every component of the immune system undergoes dramatic age-associated restructuring, leading to changes that include enhanced as well as diminished function.
Nutritional factors may be of specific importance to the onset of secondary immune deficiencies, which are common in the elderly population. It is estimated that 49 and 58% of 51-70 y olds and 70 þ y olds, respectively, are zinc inadequate (Briefel et al, 2000) . The effects of zinc deficiency on immune function have been reasonably well documented, with substantial effects reported on CMI (Shankar & Prasad, 1998; Fraker et al, 2000; Rink & Gabriel, 2000; Rink & Gabriel, 2001; Ibs & Rink, 2003) . Zinc deficiency also results in depressed innate immunity (Keen & Gershwin, 1990; Prasad, 2000; Dardenne, 2002) . It is unclear, however, at what point suboptimal zinc status may become deleterious to immune function and consequently health.
The majority of studies examining zinc status and immune function have focused on infectious disease in childhood (Bahl et al, 1998; Black, 2003; Wieringa et al, 2004 ) and the elderly (Bogden et al, 1988; Prasad et al, 1993; Ravaglia et al, 2000; Bogden, 2004; Lesourd, 2004) . There is a distinct lack of studies that have investigated the age-related changes in immune function in the late-middle-aged population (55-70 y), or indeed that have assessed zinc status of this age group. In addition, many studies investigating immune function have been based on selected samples of ageing volunteers or clinically based samples, with the most detailed studies belonging to the Senieur project of EURAGE (eg Ligthart et al, 1986) . These types of sample suffer from selection bias owing to very strict selection criteria.
The current study aims to assess and to provide an insight into the sex-specific age-related changes that occur in peripheral blood leukocyte subpopulations and putative indices of zinc status of free-living, apparently healthy 55-70 y olds recruited as part of the ZENITH study.
Subjects and methods

Study population
A total of 147 late-middle-aged individuals (77 females, 70 males) were recruited from across Northern Ireland through media coverage, leaflets, as well as national and local organisations with members spanning this age group. Of the 147 subjects recruited, 101 apparently healthy individuals were invited to take part in the study based on defined exclusion criteria, as outlined elsewhere in this issue by Polito et al (2005) . Subsequently, some 93 apparently healthy late-middle-aged individuals (48 females, 45 males), aged 55-70 y, participated in the study.
Ethical considerations
The University of Ulster Research Ethical Committee granted approval for the study. All volunteers gave informed signed consent in accordance with the declaration of Helsinki.
Study design
Following an overnight (412 h) fast, subjects were asked to attend the research centre at 0830 hours on the study day. Anthropometric measurements were determined and a firstpass urine sample was collected. Blood was immediately collected for haematological and biochemical analysis.
Anthropometric measurements
The following anthropometric parameters were evaluated: body weight, height, and blood pressure. Body mass index (BMI) was calculated as body weight (kg) divided by height (m 2 ).
Collection of peripheral blood and haematological analysis Venous blood (15 ml) was collected in K 3 EDTA and serum separation tubes. EDTA whole blood was used for determination of immune function on a FACSCalibur flow cytometer (BD Biosciences, Oxford, UK) within 4 h of collection. EDTA whole blood was also used to assess full blood profile, liver function, and kidney function at the Causeway NHS Trust Hospital Laboratory, Coleraine.
Determination of zinc status
Red blood cells and serum, stored at À201C, were analysed for zinc level by flame atomic absorption spectrometry (Perkin-Elmer 560 analyser at Grenoble University Hospital, France). Serum, stored at -201C, was analysed for alkaline phosphatase (ALP) using a commercially available kit supplied by Roche Diagnostics on a Hitachi 912 autoanalyser (Roche Diagnostics, Lewes, UK).
Leukocyte immunophenotyping
Immunophenotyping of leukocyte subsets was carried out by two-and three-colour flow cytometry using panels of conjugated-monoclonal antibodies (Table 1) . K 3 EDTA whole blood (100 ml) was incubated with conjugated-monoclonal antibodies using a lyse/wash protocol (BD Biosciences, Oxford, UK). Samples were analysed within 4 h of fixation. Percentage of positive cells was reported as obtained from FACS analysis and absolute counts were calculated from the lymphocyte white blood cell differential. On each day of testing, three-colour calibration of the FACS Calibur was conducted using CaliBritet Beads-3 (BD Biosciences, Oxford, UK), and colour compensation levels using appropriate singly stained cell suspensions. Flow cytometry data were acquired using CellQuest 3.3 for Power Macintosh (BD Biosciences, Oxford, UK) and analysed using FlowJo (version 4.5) for Macintosh (BD Biosciences, Oxford, UK).
Statistics
Reference intervals were estimated as 2.5 and 97.5 percentiles, with the median as a measure of central tendency (Solberg, 1987) . Data were normalised as appropriate. Statistical analysis was performed using a Statistical Package for Social Sciences (SPSS) version 11.0. Pearson correlations were used to analyse changes in leukocyte subpopulations with age.
Results
Characteristics of study population Subjects had a mean age of 62.4 (s.d. 4.48) y and a BMI of 26.9 (s.d. 3.22) kg/m 2 . There were no significant sex differences in age or BMI.
Determination of zinc status
Mean serum zinc and erythrocyte zinc concentrations for all subjects were 13.0 (s.d. 1.40) mM/l and 222 (s.d. 48.2) mmol/l, respectively. Normal reference ranges for serum zinc and erythrocyte zinc concentration are 11.3-18.8 and 120-250 mmol/l, respectively. There were no significant sex differences in serum or erythrocyte zinc concentration. Serum zinc concentration was inversely associated with age (r ¼ À0.226, P ¼ 0.015), while erythrocyte zinc concentration was inversely associated with age in women only (r ¼ À0.252, P ¼ 0.042). Mean alkaline phosphatase concentrations were significantly higher in women than in men (80.5 (s.d. 17 .2) U/l and 72.9 (s.d. 14.0) U/l, respectively, P ¼ 0.011).
Leukocyte immunophenotyping
Sex-specific age-related associations were observed in both relative % expression and absolute counts of peripheral blood leukocytes subpopulations (Tables 2 and 3) ; age-related associations were predominantly observed in women. Women demonstrated a significant inverse association between numbers of naïve T lymphocytes, particularly T-helper lymphocytes (CD3 þ /CD4 þ /CD45RA þ ) and age, and significant positive association between numbers of late activated T lymphocytes (CD3 þ /HLAÀDR þ ) and age. In men, a significant positive association in the relative % expression of (CD3À/CD16 þ /CD56 þ ) natural killer (NK) was observed with age. 
Discussion
The values reported in the current study for peripheral blood leukocyte subpopulations for all subjects are comparable to those reported in studies establishing reference values for leukocyte subpopulations in healthy humans (McNerlan et al, 1999; Bisset et al, 2004) . However, neither of these studies report reference values specifically for late-middleaged individuals aged 55-70 y. Thus, the current study provides useful data on immune parameters in apparently healthy humans in this age group. The current findings also highlight that changes in immune function with advancing age in this age group appear to be sex specific. Women in the current study were all postmenopausal (longer than 12 months since last menstruation); however, the exact time postmenopause and hormonal status was not determined. We speculate that our findings of sex-specific ageing are most likely to be related to the hormonal changes, and resulting physiological changes, that occur in women postmenopause. It is possible that the presence of oestrogen hormone in women delays ageing of the immune system, such that alterations occur in men at an earlier age than in women; thus resulting in our observation of different age-related associations in men and women. However, a clear understanding of the numerous effects that sex hormones have on immune function is lacking in current literature and, thus, such hypotheses cannot be confirmed (Verthelyi, 2001; Pietschmann et al, 2003; Lang, 2004 ).
In the current study, we observed significant negative associations between CMI and age in women. Specifically, a decrease in the naive T-lymphocyte population was associated with advancing age, and was especially pronounced in the T-helper subpopulation in women. Furthermore, women demonstrated a significant positive association between late T-lymphocyte activation and age. An age-related decline in naive T-lymphocyte has been associated with atrophy of the thymus that occurs from puberty (Tyan, 1981; Aspinall, 2000) . In addition, the loss of naïve T-lymphocytes, via accelerated transformation of naïve T-helper to memory T-helper (CD4 þ /CD45RO þ ) lymphocytes, and increased T-lymphocytes activation might be a natural response to cumulative exposure to new antigens during adulthood (Thoman, 1997) , thereby explaining the decline in naïve T-lymphocyte numbers.
The current study has shown that the eosinophil count is positively associated with advancing age, and that in men the relative % expression of NK cells is also positively correlated with advancing age. In has been suggested that enhanced innate immunity may occur with age as a countermeasure against declining CMI. In particular, numerous studies have reported increased numbers of NK cells (irrespective of the surface marker used to characterise them) with advancing age (for reviews, see Lesourd & Mazari, 1999; Mocchegiani & Malavolta, 2004) . Preservation of NK cell cytotoxicity and numbers in middle age may be crucial in preventing the development of some age-related diseases and achieving successful ageing; it has been demonstrated that NK cell function is the only parameter in the healthy elderly to be negatively correlated with a severe history of infection or subsequent death owing to infection (Ogata et al, 1997) .
Our findings show that the subjects included in this study had serum and erythrocyte zinc concentrations, and plasma alkaline phosphatase concentrations within the normal ranges. It is of course possible that factors such as subclinical inflammation may impact on the measurement of biological indices of zinc (Brown, 1998; Wieringa et al, 2002; Duggan et al, 2005) , and other nutrients may have had secondary effects on immune function in our study volunteers.
Between the ages of 55 and 70 y, healthy individuals experience significant alterations in immune function. Such changes, however, are largely sex specific. It is unclear what the long-term impact of suboptimal zinc intakes may be on immune function. Zinc is known to be essential for optimal immune function and our findings suggest that serum zinc concentration is negatively correlated with age; thus it is possible that maintaining optimal zinc status during latemiddle age will be advantageous to health and successful ageing, potentially mitigating against age-related changes in immune function. Clearly, further research is needed to explore the effect of improved zinc status on emerging immune deficiencies in CMI in healthy 55-70 y olds. 
